PHAT Phathom Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Jul 30, 2026
$6,92
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$6,82rendah 52m
$18,31tinggi 52m
Kapitalisasi Pasar (MRQ)
$554M
P/E (TTM)
-5.5
EPS (TTM)
$-1.25
Pendapatan (TTM)
$240M
lencana Anda
Rentang 52M
$7–$18
Peringkat Analis
BUY
Target Harga
$20
P/E
-5.5
ROE
26.4%
Margin Laba Bersih
-41.3%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
PHAT Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$6.92
Kapitalisasi Pasar (MRQ)
$554M
P/E (TTM)
-5.5
EPS (TTM)
$-1.25
Pendapatan (TTM)
$240M
ROE (TTM)
26.4%
D/E Utang/Ekuitas (MRQ)
-0.5
Rentang 52M
$7–$18
PHAT Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$175M2022-12-31 → 2025-12-31
EPS$-3.032021-12-31 → 2025-12-31
Arus Kas Bebas$-167M2019-12-31 → 2025-12-31
Margin bersih-41.3%2023-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | PHAT | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -5.5rata-rata 5T ≈-3.3 | ≈-3.3 | · | · | |
| P/S (TTM) | 2.3rata-rata 5T ≈263.8 | ≈263.8 | 2.7 | Lebih mahal | |
| P/B (MRQ) | -1.6rata-rata 5T ≈-1.9 | ≈-1.9 | · | · | |
| EV / EBITDA | -3.9rata-rata 5T ≈-3.4 | ≈-3.4 | · | · | |
| Harga / FCF (TTM) | -15.0rata-rata 5T ≈-4.0 | ≈-4.0 | · | · | |
| Harga / Arus Kas (TTM) | -15.1rata-rata 5T ≈-4.0 | ≈-4.0 | · | · | |
| EV / Revenue (EV / Pendapatan) | 3.6rata-rata 5T ≈144.3 | ≈144.3 | · | · | |
| EV / FCF | -3.8rata-rata 5T ≈-3.4 | ≈-3.4 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | PHAT | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Kotor (TTM) | 82.9%rata-rata 5T ≈82.7% | ≈82.7% | 71.8% | Tingkat teratas | |
| Margin Operasi (TTM) | -17.0%rata-rata 5T ≈-8375.4% | ≈-8375.4% | -1.8% | Di bawah rata-rata | |
| Margin EBITDA (TTM) | -16.7%rata-rata 5T ≈-8346.7% | ≈-8346.7% | 1.8% | Lemah | |
| Pretax Margin (Margin Sebelum Pajak) | -126.4% | · | -6.8% | Lemah | |
| Margin Laba Bersih (TTM) | -41.3%rata-rata 5T ≈-10096.8% | ≈-10096.8% | -7.5% | Lemah | |
| ROA (TTM) | -34.3%rata-rata 5T ≈-78.9% | ≈-78.9% | -15.7% | Lemah | |
| ROE (TTM) | 26.4%rata-rata 5T ≈175.3% | ≈175.3% | 52.3% | Sejajar | |
| ROIC | 69.8% | · | 40.3% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | PHAT | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | -0.5rata-rata 5T ≈-0.6 | ≈-0.6 | 0.0 | Utang rendah | |
| Rasio Lancar (MRQ) | 1.9rata-rata 5T ≈6.4 | ≈6.4 | 3.0 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 1.6rata-rata 5T ≈6.2 | ≈6.2 | 2.0 | Sejajar | |
| Utang Jangka Panjang / Ekuitas (MRQ) | -0.5rata-rata 5T ≈-0.6 | ≈-0.6 | 0.0 | Utang rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | PHAT | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 216.9% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | PHAT | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.5rata-rata 5T ≈0.2 | ≈0.2 | 0.5 | Tingkat teratas | |
| Inventory Turnover (Perputaran Persediaan) | 5.2rata-rata 5T ≈3.0 | ≈3.0 | 3.0 | Tingkat teratas | |
| Receivables Turnover (Perputaran Piutang) | 3.0rata-rata 5T ≈2.2 | ≈2.2 | 3.5 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$472.0K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
7.7%
Laporan Berikutnya
Okt 28, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 5, 2026 | $-0.21 | $-0.26 | 18.1% |
| 31 Maret 2026 | Mei 12, 2026 | $-0.37 | $-0.33 | -12.6% |
| 31 Des. 2025 | $-0.29 | $-0.39 | 25.5% | |
| 30 Sep. 2025 | $-0.41 | $-0.56 | 26.2% | |
| 30 Juni 2025 | $-1.05 | $-1.06 | 1.0% | |
| 31 Maret 2025 | $-1.31 | $-1.17 | -12.0% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $175M | $55M | $682.0K | $0 | |
| Cost of Revenue | $23M | $8M | $167.0K | $0 | |
| Gross Profit | $153M | $47M | $515.0K | $0 | |
| R&D Expense | $33M | $34M | $50M | $71M | |
| SG&A Expense | $280M | $291M | $118M | $101M | |
| Operating Expenses | $312M | $325M | $168M | $172M | |
| Operating Income | $-160M | $-277M | $-167M | $-172M | |
| Interest Expense | · | · | $42M | $27M | |
| Interest Income | $7M | $15M | $8M | $2M | |
| Other Non-op | $-190.0K | $-8.0K | $-188.0K | $-110.0K | |
| Pretax Income | $-221M | $-334M | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-221M | $-334M | $-202M | $-198M | |
| EPS (Basic) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| EPS (Diluted) | $-3.03 | $-5.29 | $-3.93 | $-5.05 | |
| Shares (Basic) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| Shares (Diluted) | 72,918,764 | 63,176,210 | 51,289,092 | 39,118,215 | |
| EBITDA | $-159M | $-277M | $-167M | $-172M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $130M | $297M | $381M | $155M | |
| Receivables | $78M | $39M | $2M | $0 | |
| Inventory | $6M | $3M | $1M | $0 | |
| Prepaid Expense | $15M | $21M | $13M | $5M | |
| Current Assets | $229M | $360M | $397M | $161M | |
| PP&E (Net) | $1M | $1M | $2M | $1M | |
| PP&E (Gross) | $5M | $4M | $4M | $3M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | |
| Other Non-current Assets | $3M | $2M | $2M | $299.0K | |
| Total Assets | $259M | $378M | $414M | $165M | |
| Accounts Payable | $5M | $11M | $13M | $10M | |
| Accrued Liabilities | $90M | $53M | $17M | $15M | |
| Current Liabilities | $132M | $86M | $39M | $26M | |
| Capital Leases | $2M | · | $462.0K | $1M | |
| Other Non-current Liabilities | $4M | $12M | $10M | $8M | |
| Total Liabilities | $697M | $632M | $487M | $240M | |
| Long-term Debt | $209M | $201M | $138M | $95M | |
| Total Debt | $209M | $201M | $138M | $95M | |
| Common Stock | $6.0K | $6.0K | $5.0K | $3.0K | |
| Retained Earnings | $-1.48B | $-1.26B | $-929M | $-727M | |
| Treasury Stock | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-438M | $-254M | $-73M | $-75M | |
| Liabilities + Equity | $259M | $378M | $414M | $165M | |
| Shares Outstanding | 71,419,025 | 68,518,238 | 57,970,044 | 41,468,871 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $633.0K | $795.0K | $575.0K | $620.0K | |
| Stock-based Comp | $29M | $24M | $45M | $24M | |
| Other Non-cash | $25M | $43M | $18M | $26M | |
| Operating Cash Flow | $-167M | $-267M | $-138M | $-147M | |
| CapEx | $229.0K | $135.0K | $2M | $1M | |
| Investing Cash Flow | $-229.0K | $-135.0K | $-2M | $-1M | |
| Debt Issued | $0 | $59M | $39M | $0 | |
| Net Debt Issued | $0 | $59M | $39M | · | |
| Stock Issued | · | · | $14M | · | |
| Financing Cash Flow | $-288.0K | $183M | $368M | $120M | |
| Net Change in Cash | $-167M | $-84M | $228M | $-28M | |
| Free Cash Flow | $-167M | $-267M | $-139M | $-148M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 87.1% | 85.6% | 75.5% | · | |
| Operating Margin | -91.4% | -502.2% | -24532.5% | · | |
| Net Margin | -126.4% | -605.1% | -29558.9% | · | |
| Pretax Margin | -126.4% | · | · | · | |
| EBITDA Margin | -91.0% | -500.8% | -24448.2% | · | |
| ROA | -69.4% | -84.4% | -69.7% | -111.6% | |
| ROE | 52.4% | 151.7% | 445.4% | 390.6% | |
| ROIC | 69.8% | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.7 | 4.2 | 10.2 | 6.1 | |
| Quick Ratio | 1.6 | 3.9 | 9.9 | 5.9 | |
| Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| LT Debt / Equity | -0.5 | -0.8 | -1.9 | -1.3 | |
| Interest Coverage | · | · | -4.0 | -6.3 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.1 | 0.0 | · | |
| Inventory Turnover | 5.2 | 3.6 | 0.3 | · | |
| Receivables Turnover | 3.0 | 2.7 | 0.8 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $-6.14 | $-4.37 | $-1.26 | $-1.80 | |
| Revenue / Share | $2.40 | $0.87 | $0.01 | · | |
| Cash Flow / Share | $-2.29 | $-4.22 | $-2.68 | $-3.75 | |
| Cash / Share | $1.82 | $5.13 | $6.58 | $3.75 | |
| EPS (TTM) | $-3.03 | $-5.29 | $-3.93 | $-5.05 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 216.9% | 8001.5% | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $175M | $55M | $682.0K | $0 | |
| Net Income TTM | $-221M | $-334M | $-202M | $-198M | |
| Market Cap | $1.18B | $471M | $529M | $465M | |
| Enterprise Value | $1.26B | $375M | $286M | $405M | |
| P/E | -5.5 | -1.5 | -2.3 | -2.2 | |
| P/S | 6.8 | 8.5 | 776.1 | · | |
| P/B | -2.7 | -1.9 | -7.3 | -6.2 | |
| P / Cash Flow | -7.1 | -1.8 | -3.8 | -3.2 | |
| P / FCF | -7.1 | -1.8 | -3.8 | -3.2 | |
| EV / EBITDA | -7.9 | -1.4 | -1.7 | -2.4 | |
| EV / FCF | -7.6 | -1.4 | -2.1 | -2.7 | |
| EV / Revenue | 7.2 | 6.8 | 418.9 | · | |
| Earnings Yield | -18.3% | -65.1% | -43.0% | -45.0% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $74M | $58M | $58M | $50M | $40M | $29M | $30M | $16M | $7M | $2M | $682.0K | $0 | $0 | $0 | |
| Cost of Revenue | $15M | $12M | $8M | $6M | $5M | $4M | $4M | $2M | $1M | $426.0K | $167.0K | $0 | $0 | $0 | |
| Gross Profit | $59M | $46M | $50M | $43M | $34M | $25M | $26M | $14M | $6M | $1M | $515.0K | $0 | $0 | $0 | |
| R&D Expense | $8M | $8M | $7M | $7M | $9M | $9M | $9M | $9M | $7M | $9M | $13M | $12M | $13M | $11M | |
| SG&A Expense | $55M | $54M | $48M | $52M | $85M | $94M | $77M | $76M | $76M | $62M | $57M | $23M | $19M | $19M | |
| Operating Expenses | $63M | $62M | $56M | $59M | $94M | $104M | $85M | $85M | $83M | $71M | $70M | $36M | $32M | $30M | |
| Operating Income | $-4M | $-15M | $-6M | $-15M | $-60M | $-79M | $-59M | $-71M | $-77M | $-70M | $-70M | $-36M | $-32M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | $18M | $17M | · | $10M | $10M | $9M | |
| Interest Income | $2M | $2M | $1M | $1M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $348.0K | $1M | |
| Other Non-op | $-24.0K | $-831.0K | $-6.0K | $-7.0K | $-155.0K | $-22.0K | $49.0K | $-8.0K | $-6.0K | $-43.0K | $-14.0K | $-197.0K | $3.0K | $20.0K | |
| Net Income | $-18M | $-30M | $-21M | $-30M | $-76M | $-94M | $-74M | $-86M | $-91M | $-83M | $-80M | $-43M | $-41M | $-38M | |
| EPS (Basic) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| EPS (Diluted) | $-0.21 | $-0.37 | $-0.26 | $-0.41 | $-1.05 | $-1.31 | $-0.99 | $-1.32 | $-1.56 | $-1.42 | $-1.44 | $-0.76 | $-0.84 | $-0.89 | |
| Shares (Basic) | 83,747,104 | 82,050,618 | · | 73,396,435 | 72,466,203 | 71,969,411 | · | 64,627,847 | 58,558,145 | 58,371,480 | · | 56,782,379 | 48,500,516 | 42,354,520 | |
| Shares (Diluted) | 83,747,104 | 82,050,618 | · | 73,396,435 | 72,466,203 | 71,969,411 | · | 64,627,847 | 58,558,145 | 58,371,480 | · | 56,782,379 | 48,500,516 | 42,354,520 | |
| EBITDA | $-4M | $-15M | · | $-15M | $-60M | $-79M | · | $-71M | $-77M | $-70M | · | $-36M | $-32M | $-30M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $182M | $181M | $130M | $135M | $150M | $212M | $297M | $335M | $276M | $322M | $381M | $214M | $249M | $130M | |
| Receivables | $97M | $81M | $78M | $56M | $51M | $36M | $39M | $21M | $11M | $4M | $2M | · | · | · | |
| Inventory | $8M | $7M | $6M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $1M | $111.0K | $111.0K | · | |
| Prepaid Expense | $8M | $8M | $15M | $13M | $15M | $13M | $21M | $15M | $15M | $13M | $13M | $13M | $9M | $10M | |
| Current Assets | $296M | $277M | $229M | $208M | $219M | $265M | $360M | $374M | $305M | $340M | $397M | $227M | $258M | $140M | |
| PP&E (Net) | $971.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | $5M | · | · | · | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $299.0K | |
| Total Assets | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Accounts Payable | $5M | $6M | $5M | $1M | $4M | $12M | $11M | $7M | $8M | $8M | $13M | $6M | $4M | $5M | |
| Accrued Liabilities | $109M | $83M | $90M | $65M | $64M | $43M | $53M | $36M | $27M | $17M | $17M | $13M | $15M | $8M | |
| Current Liabilities | $154M | $125M | $132M | $93M | $92M | $74M | $86M | $65M | $47M | $43M | $39M | $24M | $22M | $14M | |
| Capital Leases | $2M | $2M | $2M | $2M | $589.0K | $0 | · | $0 | $133.0K | $292.0K | $462.0K | $628.0K | $789.0K | $945.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | $12M | $12M | $12M | $12M | $11M | $10M | $10M | $10M | $8M | $8M | $8M | |
| Total Liabilities | $671M | $642M | $697M | $663M | $656M | $633M | $632M | $574M | $553M | $505M | $487M | $255M | $247M | $234M | |
| Long-term Debt | $165M | $164M | $209M | $207M | $205M | $203M | $201M | $176M | $174M | $149M | $138M | $99M | $98M | $97M | |
| Total Debt | $165M | $164M | · | $207M | $205M | $203M | · | $176M | $174M | $149M | · | $99M | $98M | $97M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-1.53B | $-1.51B | $-1.48B | $-1.46B | $-1.43B | $-1.36B | $-1.26B | $-1.19B | $-1.10B | $-1.01B | $-929M | $-849M | $-806M | $-765M | |
| Treasury Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $-344M | $-337M | $-438M | $-423M | $-406M | $-338M | $-254M | $-187M | $-234M | $-149M | $-73M | $-18M | $18M | $-90M | |
| Liabilities + Equity | $327M | $305M | $259M | $240M | $250M | $294M | $378M | $387M | $319M | $356M | $414M | $237M | $265M | $144M | |
| Shares Outstanding | 80,070,048 | 79,442,367 | 71,419,025 | 71,043,149 | 70,104,419 | 69,638,070 | 68,518,238 | 68,323,938 | 58,601,025 | 58,524,101 | 57,970,044 | 56,809,085 | 56,639,085 | 43,571,140 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $114.0K | $110.0K | $128.0K | $156.0K | $172.0K | $177.0K | $193.0K | $191.0K | $197.0K | $214.0K | $185.0K | $121.0K | $123.0K | $146.0K | |
| Stock-based Comp | $7M | $6M | $6M | $9M | $8M | $6M | $7M | $6M | $6M | $6M | $25M | $6M | $7M | $7M | |
| Other Non-cash | · | $9M | · | · | · | $4M | · | · | · | $8M | · | · | · | $-9M | |
| Operating Cash Flow | $-2M | $-16M | $-5M | $-14M | $-63M | $-85M | $-63M | $-64M | $-71M | $-69M | $-44M | $-32M | $-22M | $-40M | |
| CapEx | $44.0K | $61.0K | $87.0K | $27.0K | $97.0K | $18.0K | $5.0K | $44.0K | $46.0K | $40.0K | $475.0K | $939.0K | $6.0K | $214.0K | |
| Investing Cash Flow | $-44.0K | $-61.0K | $-87.0K | $-27.0K | $-97.0K | $-18.0K | $-5.0K | $-44.0K | $-46.0K | $-40.0K | $-475.0K | $-939.0K | $-6.0K | $-214.0K | |
| Debt Issued | $0 | $173M | $0 | $0 | $0 | $0 | $25M | $0 | $25M | $10M | $39M | $0 | $0 | $0 | |
| Net Debt Issued | · | $-56M | · | · | · | $0 | · | · | · | $10M | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $4M | $67M | $-97.0K | $-271.0K | $80.0K | $0 | $26M | $122M | $25M | $10M | $212M | $13.0K | $142M | $14M | |
| Net Change in Cash | $2M | $51M | $-5M | $-14M | $-63M | $-85M | $-37M | $58M | $-46M | $-59M | $168M | $-33M | $119M | $-26M | |
| Free Cash Flow | · | $-16M | · | · | · | $-85M | · | · | · | $-69M | · | · | · | $-40M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 79.7% | 79.4% | · | 87.5% | 87.2% | 86.9% | · | 85.6% | 81.2% | 77.7% | · | · | · | · | |
| Operating Margin | -5.3% | -26.6% | · | -30.9% | -151.7% | -276.5% | · | -433.0% | -1055.4% | -3658.7% | · | · | · | · | |
| Net Margin | -23.7% | -52.1% | · | -60.6% | -191.9% | -330.7% | · | -523.3% | -1248.6% | -4333.3% | · | · | · | · | |
| EBITDA Margin | -5.3% | -26.4% | · | -30.9% | -151.7% | -275.9% | · | -433.0% | -1055.4% | -3647.5% | · | · | · | · | |
| ROA | -6.1% | -10.1% | · | -9.6% | -26.6% | -29.0% | · | -27.4% | -31.3% | -33.1% | · | -19.7% | -17.1% | -25.8% | |
| ROE | 4.7% | 9.0% | · | 9.8% | 23.7% | 38.7% | · | 83.5% | 84.6% | 69.4% | · | 195.7% | -772.9% | 145.0% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 2.2 | · | 2.2 | 2.4 | 3.6 | · | 5.7 | 6.5 | 7.8 | · | 9.5 | 12.0 | 9.7 | |
| Quick Ratio | 1.8 | 2.1 | · | 2.1 | 2.2 | 3.4 | · | 5.4 | 6.1 | 7.5 | · | 8.9 | 11.6 | 9.0 | |
| Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| LT Debt / Equity | -0.5 | -0.5 | · | -0.5 | -0.5 | -0.6 | · | -0.9 | -0.7 | -1.0 | · | -5.6 | 5.6 | -1.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -4.4 | -4.1 | · | -3.5 | -3.3 | -3.3 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | · | · | · | |
| Inventory Turnover | 2.7 | 2.5 | · | 1.8 | 1.8 | 1.6 | · | 1.5 | 1.2 | 0.6 | · | · | · | · | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.3 | 1.3 | 1.4 | · | 1.6 | 1.3 | 1.0 | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.30 | $-4.24 | · | $-5.95 | $-5.79 | $-4.86 | · | $-2.74 | $-3.99 | $-2.54 | · | $-0.31 | $0.31 | $-2.07 | |
| Revenue / Share | $0.89 | $0.71 | · | $0.67 | $0.55 | $0.40 | · | $0.25 | $0.13 | $0.03 | · | · | · | · | |
| Cash Flow / Share | · | $-0.19 | · | · | · | $-1.18 | · | · | · | $-1.18 | · | · | · | $-0.94 | |
| Cash / Share | $2.28 | $2.28 | · | $1.90 | $2.13 | $3.05 | · | $4.90 | $4.71 | $5.51 | · | $3.76 | $4.39 | $2.97 | |
| EPS (TTM) | $-1.25 | $-2.09 | · | $-3.76 | $-4.67 | $-5.18 | · | $-5.74 | $-5.18 | $-4.46 | · | $-3.82 | $-4.38 | $-4.87 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $240M | $205M | · | $147M | $114M | $82M | · | $26M | $10M | $3M | · | · | · | · | |
| Net Income TTM | $-99M | $-157M | · | $-275M | $-330M | $-346M | · | $-339M | $-297M | $-247M | · | $-177M | $-185M | $-195M | |
| Market Cap | $869M | $883M | · | $836M | $672M | $437M | · | $1.24B | $604M | $622M | · | $589M | $811M | $311M | |
| Enterprise Value | $851M | $865M | · | $908M | $728M | $428M | · | $1.08B | $502M | $448M | · | $475M | $660M | $278M | |
| P/E | -8.7 | -5.3 | · | -3.1 | -2.1 | -1.2 | · | -3.1 | -2.0 | -2.4 | · | -2.7 | -3.3 | -1.5 | |
| P/S | 3.6 | 4.3 | · | 5.7 | 5.9 | 5.3 | · | 47.0 | 60.9 | 239.6 | · | · | · | · | |
| P/B | -2.5 | -2.6 | · | -2.0 | -1.7 | -1.3 | · | -6.6 | -2.6 | -4.2 | · | -33.1 | 46.1 | -3.4 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 46.1 | · | |
| P / Cash Flow | · | -56.4 | · | · | · | -5.1 | · | · | · | -9.0 | · | · | · | -7.8 | |
| EV / Revenue | 3.6 | 4.2 | · | 6.2 | 6.4 | 5.2 | · | 41.0 | 50.6 | 172.8 | · | · | · | · | |
| Earnings Yield | -11.5% | -18.8% | · | -31.9% | -48.7% | -82.6% | · | -31.8% | -50.3% | -42.0% | · | -36.8% | -30.6% | -68.2% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $175M | $55M | $682.0K | $0 | · |
| Margin Kotor % | 87.1% | 85.6% | 75.5% | · | · |
| Margin Operasi % | -91.4% | -502.2% | -24532.5% | · | · |
| Laba Bersih | $-221M | $-334M | $-202M | $-198M | $-144M |
| EPS Dilusian | $-3.03 | $-5.29 | $-3.93 | $-5.05 | $-3.89 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | -0.5 | -0.8 | -1.9 | -1.3 | 1.2 |
| Rasio Lancar | 1.7 | 4.2 | 10.2 | 6.1 | 9.9 |
| Rasio Cepat | 1.6 | 3.9 | 9.9 | 5.9 | 9.7 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-167M | $-267M | $-139M | $-148M | $-149M |
Pemilik institusional (13F) 176 pengaju · $818.8M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
176
Nilai yang dipegang
$818.8M
Posisi baru
26
Posisi yang keluar
31
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 26 (-13 vs Kuartal sebelumnya) | 31 (-4 vs Kuartal sebelumnya) | 59 (-16 vs Kuartal sebelumnya) | 52 (+12 vs Kuartal sebelumnya) | +5.7M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $135.261.406 | 12.466.489 | 16,52% | Saham |
| Medicxi Ventures Management (Jersey) Ltd | $80.990.606 | 7.464.572 | 9,89% | Saham |
| VANGUARD GROUP INC | $52.709.931 | 3.177.211 | 6,44% | Saham |
| BlackRock, Inc. | $49.097.648 | 4.525.129 | 6,00% | Saham |
| Invesco Ltd. | $43.722.581 | 4.029.731 | 5,34% | Saham |
| Carlyle Group Inc. | $37.940.367 | 3.496.808 | 4,63% | Saham |
| MILLENNIUM MANAGEMENT LLC | $36.627.799 | 3.375.834 | 4,47% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $28.827.842 | 2.656.944 | 3,52% | Saham |
| FRANKLIN RESOURCES INC | $21.383.482 | 1.970.828 | 2,61% | Saham |
| NEA Management Company, LLC | $21.267.834 | 1.960.169 | 2,60% | Saham |
| 683 Capital Management, LLC | $20.072.501 | 1.850.000 | 2,45% | Saham |
| GOLDMAN SACHS GROUP INC | $19.291.647 | 1.778.032 | 2,36% | Saham |
| STATE STREET CORP | $17.211.605 | 1.586.323 | 2,10% | Saham |
| Catalys Pacific, LLC | $16.208.316 | 1.493.854 | 1,98% | Saham |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $15.871.000 | 1.462.738 | 1,94% | Saham |
| WASATCH ADVISORS LP | $14.897.577 | 1.340.916 | 1,82% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $14.277.589 | 1.315.687 | 1,74% | Saham |
| Ensign Peak Advisors, Inc | $11.413.256 | 1.051.913 | 1,39% | Saham |
| Propel Bio Management, LLC | $11.396.384 | 1.050.358 | 1,39% | Saham |
| Point72 Asset Management, L.P. | $11.090.794 | 1.022.193 | 1,35% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8.643.446 | 796.631 | 1,06% | Saham |
| SummitTX Capital, L.P. | $8.566.618 | 789.550 | 1,05% | Saham |
| HSBC HOLDINGS PLC | $7.701.936 | 709.695 | 0,94% | Saham |
| MARSHALL WACE, LLP | $7.227.078 | 666.090 | 0,88% | Saham |
| EcoR1 Capital, LLC | $6.781.250 | 625.000 | 0,83% | Saham |
| PERCEPTIVE ADVISORS LLC | $5.772.200 | 532.000 | 0,70% | Saham |
| TWO SIGMA INVESTMENTS, LP | $5.631.975 | 519.076 | 0,69% | Saham |
| CITADEL ADVISORS LLC | $5.216.680 | 480.800 | 0,64% | Opsi beli |
| NORTHERN TRUST CORP | $4.972.565 | 458.301 | 0,61% | Saham |
| StepStone Group LP | $4.689.364 | 422.085 | 0,57% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.547.170 | 419.094 | 0,56% | Saham |
| Woodline Partners LP | $4.004.214 | 369.052 | 0,49% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $3.847.117 | 354.573 | 0,47% | Saham |
| AMERIPRISE FINANCIAL INC | $3.189.673 | 293.979 | 0,39% | Saham |
| JPMORGAN CHASE & CO | $2.991.978 | 275.251 | 0,37% | Saham |
| Simplify Asset Management Inc. | $2.704.547 | 249.267 | 0,33% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $2.456.440 | 226.400 | 0,30% | Saham |
| JANE STREET GROUP, LLC | $2.307.860 | 212.706 | 0,28% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.281.755 | 210.300 | 0,28% | Opsi beli |
| UBS Group AG | $2.219.618 | 204.573 | 0,27% | Saham |
| NewEdge Advisors, LLC | $2.212.988 | 203.962 | 0,27% | Saham |
| Avidity Partners Management LP | $2.170.000 | 200.000 | 0,27% | Saham |
| MORGAN STANLEY | $2.169.013 | 199.909 | 0,26% | Saham |
| Jump Financial, LLC | $2.081.746 | 191.866 | 0,25% | Saham |
| Opaleye Management Inc. | $2.013.641 | 185.589 | 0,25% | Saham |
| CITADEL ADVISORS LLC | $2.006.176 | 184.901 | 0,25% | Saham |
| Trexquant Investment LP | $1.886.641 | 173.884 | 0,23% | Saham |
| Jones Hill Capital LP | $1.752.123 | 161.486 | 0,21% | Saham |
| Bank of New York Mellon Corp | $1.652.595 | 152.313 | 0,20% | Saham |
| WELLS FARGO & COMPANY/MN | $1.649.221 | 152.002 | 0,20% | Saham |
Aktivis & pemilik 5%+ 5 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×3 pengajuan | 4 Nov. 2025 | 8,60% | Amandemen | · | SEC |
| Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes ×8 pengajuan | 22 Agu 2024 | · | Pengajuan awal | Investasi pasif | SEC |
| Takeda Pharmaceutical Company Limited ×3 pengajuan | 10 April 2024 | · | Pengajuan awal | · | SEC |
| Frazier Life Sciences IX, L.P ., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., James N. Topper, Patrick J. Heron, Albert Cha, James Brush, Daniel Estes | 26 Mei 2023 | · | Pengajuan awal | Investasi pasif | SEC |
| S.S. OR ×5 pengajuan | 12 Nov. 2021 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 20 orang dalam · 9 pejabat · 12 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Steven L Basta | President and CEO | 10 Feb. 2026 F | 373.315 | 0 | 0 | $0 |
| Molly Henderson | CFO and CBO | 7 April 2025 S | 89.868 | 0 | 0 | $0 |
| Todd P. Branning | Chief Financial Officer | 28 Jan. 2021 A | · | 0 | 0 | $0 |
| Terrie Curran | President and Chief Executive | 27 Feb. 2025 A | 360.465 | 0 | 0 | $0 |
| Azmi Nabulsi | Chief Operating Officer | 27 Feb. 2025 A | 312.590 | 0 | 0 | $0 |
| Robert Charles Breedlove | Principal Accounting Officer | 3 Sep. 2026 F | 59.465 | 0 | 1 | $-7.079 |
| Anne Marie Cook | Chief Legal Off. & Corp. Sec. | 10 Feb. 2026 F | 88.660 | 0 | 0 | $0 |
| Sanjeev Narula | Chief Financial & Bus. Officer | 2 Jan. 2026 A | 226.715 | 0 | 0 | $0 |
| Anthony J. Guzzo | VP, Chief Accounting Officer | 19 Jan. 2022 A | 8.399 | 0 | 0 | $0 |
| Asit Parikh | Direktur | 22 Mei 2026 G | 148.500 | 0 | 0 | $0 |
| Mark Stenhouse | Direktur | 19 Mei 2026 A | 54.122 | 0 | 0 | $0 |
| Theodore R Schroeder | Direktur | 19 Mei 2026 A | 45.122 | 0 | 0 | $0 |
| James N. Topper | Direktur | 19 Mei 2026 A | 66.718 | 0 | 0 | $0 |
| Frank Karbe | Direktur | 19 Mei 2026 A | 91.622 | 0 | 0 | $0 |
| Michael F Cola | Direktur | 19 Mei 2026 A | 63.920 | 0 | 0 | $0 |
| Heidi Kunz | Direktur | 19 Mei 2026 A | 54.122 | 0 | 0 | $0 |
| David A Socks | Direktur | 23 Mei 2024 A | 19.500 | 0 | 0 | $0 |
| Tadataka Yamada | Direktur | 21 Mei 2021 A | · | 0 | 0 | $0 |
| Jonathan S. Edwards | Direktur | 29 Okt. 2019 C | 47.984 | 0 | 0 | $0 |
| Takeda Pharmaceutical Company Limited | · | 24 Jan. 2024 S | 3.755.583 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 24 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,16% | 130.873 NS | 31 Juli 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 0,64% | 15.083 NS | 31 Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,10% | 167.720 SH | 11 Sep. 2026 | Harian |
| IHE · iShares Trust | 0,10% | 187.890 SH | 11 Sep. 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 78.352 SH | 19 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 5.742 SH | 2 Okt. 2026 | Harian |
| IBB · iShares Trust | 0,04% | 439.273 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 283.184 SH | 19 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 30.521 SH | 19 Agu 2026 | Harian |
| ISCG · iShares Trust | 0,02% | 18.633 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,01% | 23.493 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.255.887 SH | 11 Sep. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 586.438 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 15.003 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 148.237 SH | 19 Agu 2026 | Harian |
| IWO · iShares Trust | 0,01% | 132.821 SH | 11 Sep. 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 22.619 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 2.597 SH | 11 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,00% | 79.252 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 9.388 SH | 3 Sep. 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.007.668 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.478 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 330.692 SH | 11 Sep. 2026 | Harian |
| ISCB · iShares Trust | · | 2.641 SH | 11 Sep. 2026 | Harian |
PHAT Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 17 analis
BELI
Target median
$21.00
+203,5%
6 35,3%
Beli Kuat
9 52,9%
Beli
2 11,8%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
11 analis · 2026-09-29Target rata-rata $20.45 +195,6%
← Di bawah semua target
Harga saat ini $6.92
Rendah$10.00
Rata-rata$20.45
Tinggi$29.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | · |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | · |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | · |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| CTNM | · | -5.3 | · | · | -27.7% | · |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | · |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Jul 30, 2026